RPG Life Sciences Limited (BOM:532983)
1,997.35
-18.30 (-0.91%)
At close: Apr 21, 2026
RPG Life Sciences Revenue
RPG Life Sciences had revenue of 1.80B INR in the quarter ending December 31, 2025, with 4.24% growth. This brings the company's revenue in the last twelve months to 6.74B, up 5.71% year-over-year. In the fiscal year ending March 31, 2025, RPG Life Sciences had annual revenue of 6.53B with 12.26% growth.
Revenue (ttm)
6.74B
Revenue Growth
+5.71%
P/S Ratio
4.91
Revenue / Employee
5.06M
Employees
1,331
Market Cap
33.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.53B | 713.80M | 12.26% |
| Mar 31, 2024 | 5.82B | 692.40M | 13.50% |
| Mar 31, 2023 | 5.13B | 726.50M | 16.51% |
| Mar 31, 2022 | 4.40B | 510.20M | 13.11% |
| Mar 31, 2021 | 3.89B | 135.70M | 3.61% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Unichem Laboratories | 22.14B |
| FDC Limited | 20.78B |
| Morepen Laboratories | 17.87B |
| Hikal | 17.46B |
| Gufic Biosciences | 8.97B |
| Bliss GVS Pharma | 8.68B |
| Venus Remedies | 7.03B |
| Amrutanjan Health Care | 4.88B |
RPG Life Sciences News
- 3 months ago - Why are RPG Life Sciences shares falling over 10% today? Explained - Business Upturn
- 6 months ago - RPG Life Sciences Ltd (BOM:532983) Q2 2026 Earnings Call Highlights: Strong Domestic Growth and ... - GuruFocus
- 6 months ago - Q2 2026 RPG Life Sciences Ltd Earnings Call Transcript - GuruFocus
- 9 months ago - RPG Life Sciences drops nearly 6% following Q1 results - Business Upturn
- 1 year ago - RPG Life Sciences shares surge nearly 8% after Q4 net profit jumps 786% on one-time land gain - Business Upturn
- 1 year ago - RPG Life Sciences surges 9.36% on robust Q3 FY25 earnings; net profit up 32% YoY - Business Upturn
- 1 year ago - Stocks in focus today, January 27, 2025: JK Cement, Balkrishna Industries, Shakti Pumps, Yes Bank, KEC International, Trident, RPG Life Sciences, Jubilant Pharmova - Business Upturn
- 1 year ago - RPG Life Sciences reports fire incident at manufacturing plant in Navi Mumbai - Business Upturn